Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

STEVEN CHASE STROUD

Allopathic & Osteopathic Physicians Internal Medicine Advanced Heart Failure and Transplant Cardiology

NPI
1730567124
CMS profile
1350592
Location
TULSA, OK

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$10,520.28

125 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $4,719.32 120
Consulting Fee $4,200.00 1
Travel and Lodging $1,600.96 4

By paying entity

PY2024 · entire year · sorted by reported total

Page 2 of 3; records 51–100 of 125 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

STEVEN CHASE STROUD

NPI 1730567124 · CMS profile ID 1350592

Allopathic & Osteopathic Physicians / Internal Medicine / Advanced Heart Failure and Transplant Cardiology

TULSA, OK

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 125 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1730567124?year=2024&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
STEVEN CHASE STROUD, NPI 1730567124, CMS profile ID 1350592. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 125 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1730567124?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). STEVEN CHASE STROUD, NPI 1730567124, CMS profile ID 1350592. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 125 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1730567124?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
STEVEN CHASE STROUD, NPI 1730567124, CMS profile ID 1350592, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 125 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1730567124?year=2024&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

125 matching records · $10,520.28 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 125 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 125.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
United Therapeutics Corporation $21.9807/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1149468668 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $16.3107/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1118132427 CMS
Merck Sharp & Dohme LLC $17.1707/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141776637 CMS
United Therapeutics Corporation $60.7807/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1149455422 CMS
Lexicon Pharmaceuticals, Inc. $107.3807/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1081726817 CMS
Merck Sharp & Dohme LLC $103.9507/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141702601 CMS
Actelion Pharmaceuticals US, Inc. $22.0407/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078866595 CMS
Abbott Laboratories $28.6307/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1125226388 CMS
Abbott Laboratories $10.5907/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1125226400 CMS
Merck Sharp & Dohme LLC $14.9207/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141702813 CMS
United Therapeutics Corporation $26.8006/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1149454701 CMS
E.R. Squibb & Sons, L.L.C. $12.9906/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101265275 CMS
E.R. Squibb & Sons, L.L.C. $5.0306/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101265285 CMS
Abbott Laboratories $23.6806/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1125226384 CMS
Actelion Pharmaceuticals US, Inc. $4,200.0006/20/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078866939 CMS
ABIOMED $135.4806/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1142238080 CMS
Actelion Pharmaceuticals US, Inc. $20.0006/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078866725 CMS
Actelion Pharmaceuticals US, Inc. $60.0006/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078866733 CMS
Actelion Pharmaceuticals US, Inc. $33.5906/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078866743 CMS
Actelion Pharmaceuticals US, Inc. $20.0006/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078866845 CMS
Actelion Pharmaceuticals US, Inc. $40.0006/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078866929 CMS
Actelion Pharmaceuticals US, Inc. $215.4606/12/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078866731 CMS
Actelion Pharmaceuticals US, Inc. $150.0006/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078866741 CMS
United Therapeutics Corporation $19.5606/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1149453874 CMS
Merck Sharp & Dohme LLC $13.1006/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141702807 CMS
Actelion Pharmaceuticals US, Inc. $673.4906/04/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078866853 CMS
Impulse Dynamics (USA) Inc. $15.3005/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1100421473 CMS
E.R. Squibb & Sons, L.L.C. $2.6305/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101265277 CMS
ABIOMED $125.0005/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1142237824 CMS
AstraZeneca Pharmaceuticals LP $9.0405/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104276773 CMS
Merck Sharp & Dohme LLC $11.4405/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141933705 CMS
United Therapeutics Corporation $101.8505/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1149462452 CMS
Edwards Lifesciences Corporation $139.7605/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1138797272 CMS
United Therapeutics Corporation $21.8605/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1149467324 CMS
Abbott Laboratories $146.8904/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1125226380 CMS
Bayer Healthcare Pharmaceuticals Inc. $19.8704/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086249262 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $22.8004/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1118132431 CMS
Edwards Lifesciences Corporation $17.4404/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1138797274 CMS
Merck Sharp & Dohme LLC $18.6604/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141702815 CMS
Kestra Medical Technology Services, Inc. $28.6704/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1152374221 CMS
E.R. Squibb & Sons, L.L.C. $10.8204/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101265261 CMS
E.R. Squibb & Sons, L.L.C. $21.6304/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101265263 CMS
AstraZeneca Pharmaceuticals LP $26.1904/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104231097 CMS
Merck Sharp & Dohme LLC $15.6904/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141705450 CMS
Actelion Pharmaceuticals US, Inc. $14.0804/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078866599 CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $33.1304/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1080703464 CMS
Abbott Laboratories $23.1904/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1125226372 CMS
Abbott Laboratories $16.5604/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1125226376 CMS
Merck Sharp & Dohme LLC $14.7604/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141702811 CMS
Actelion Pharmaceuticals US, Inc. $19.2003/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078866773 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $263.45 4
PY2021 $120.09 5
PY2022 $923.50 31
PY2023 $8,313.90 120
PY2024 $10,520.28 125
PY2025 $19,072.17 122

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Source files
Dataset page · Bulk file · PY2019 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $516,277.36 21
PY2024 Principal investigator $574,464.43 13

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

21 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 United Therapeutics Corporation $1,300.00 12/24/2025 Non-covered Recipient Entity
OKLAHOMA HEART RESEARCH AND EDUCATION FOUNDATION
A PHASE 4, PROSPECTIVE, MULTICENTER, SINGLE-ARM STUDY OF A MEAN PULMONARY ARTERY PRESSURE-TARGETED APPROACH WITH EARLY AND RAPID TREPROSTINIL THERAPY TO REVERSE RIGHT VENTRICULAR REMODELING IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION: ARTISAN (AFTERLOAD REDUCTION TO IMPROVE RIGHT VENTRICULAR STRUCTURE AND FUNCTION) No dispute reported 06/30/2026 1242387137
Principal investigator 1 United Therapeutics Corporation $975.00 11/26/2025 Non-covered Recipient Entity
OKLAHOMA HEART RESEARCH AND EDUCATION FOUNDATION
A PHASE 4, PROSPECTIVE, MULTICENTER, SINGLE-ARM STUDY OF A MEAN PULMONARY ARTERY PRESSURE-TARGETED APPROACH WITH EARLY AND RAPID TREPROSTINIL THERAPY TO REVERSE RIGHT VENTRICULAR REMODELING IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION: ARTISAN (AFTERLOAD REDUCTION TO IMPROVE RIGHT VENTRICULAR STRUCTURE AND FUNCTION) No dispute reported 06/30/2026 1242387131
Principal investigator 1 United Therapeutics Corporation $2,492.28 11/12/2025 Non-covered Recipient Entity
OKLAHOMA HEART RESEARCH AND EDUCATION FOUNDATION
A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) No dispute reported 06/30/2026 1242387159
Principal investigator 2 Edwards Lifesciences Corporation $80,942.00 10/22/2025 Non-covered Recipient Entity
Oklahoma Heart Research & Education Foundation
ALT-FLOW II 2022-06 No dispute reported 06/30/2026 1222705984
Principal investigator 1 United Therapeutics Corporation $2,015.00 10/22/2025 Non-covered Recipient Entity
OKLAHOMA HEART RESEARCH AND EDUCATION FOUNDATION
A PHASE 4, PROSPECTIVE, MULTICENTER, SINGLE-ARM STUDY OF A MEAN PULMONARY ARTERY PRESSURE-TARGETED APPROACH WITH EARLY AND RAPID TREPROSTINIL THERAPY TO REVERSE RIGHT VENTRICULAR REMODELING IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION: ARTISAN (AFTERLOAD REDUCTION TO IMPROVE RIGHT VENTRICULAR STRUCTURE AND FUNCTION) No dispute reported 06/30/2026 1242387143
Principal investigator 1 United Therapeutics Corporation $6,700.00 10/22/2025 Non-covered Recipient Entity
OKLAHOMA HEART RESEARCH AND EDUCATION FOUNDATION
A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) No dispute reported 06/30/2026 1242387163
Principal investigator 1 United Therapeutics Corporation $6,745.43 09/24/2025 Non-covered Recipient Entity
OKLAHOMA HEART RESEARCH AND EDUCATION FOUNDATION
A PHASE 4, PROSPECTIVE, MULTICENTER, SINGLE-ARM STUDY OF A MEAN PULMONARY ARTERY PRESSURE-TARGETED APPROACH WITH EARLY AND RAPID TREPROSTINIL THERAPY TO REVERSE RIGHT VENTRICULAR REMODELING IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION: ARTISAN (AFTERLOAD REDUCTION TO IMPROVE RIGHT VENTRICULAR STRUCTURE AND FUNCTION) No dispute reported 06/30/2026 1242387157
Principal investigator 1 United Therapeutics Corporation $2,500.00 09/17/2025 Non-covered Recipient Entity
OKLAHOMA HEART RESEARCH AND EDUCATION FOUNDATION
A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) No dispute reported 06/30/2026 1242387161
Principal investigator 1 United Therapeutics Corporation $2,990.00 09/10/2025 Non-covered Recipient Entity
OKLAHOMA HEART RESEARCH AND EDUCATION FOUNDATION
A PHASE 4, PROSPECTIVE, MULTICENTER, SINGLE-ARM STUDY OF A MEAN PULMONARY ARTERY PRESSURE-TARGETED APPROACH WITH EARLY AND RAPID TREPROSTINIL THERAPY TO REVERSE RIGHT VENTRICULAR REMODELING IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION: ARTISAN (AFTERLOAD REDUCTION TO IMPROVE RIGHT VENTRICULAR STRUCTURE AND FUNCTION) No dispute reported 06/30/2026 1242387149
Principal investigator 2 Edwards Lifesciences Corporation $150,692.90 07/10/2025 Non-covered Recipient Entity
Oklahoma Heart Research & Education Foundation
ALT-FLOW II 2022-06 No dispute reported 06/30/2026 1222705956
Principal investigator 1 United Therapeutics Corporation $1,235.00 07/08/2025 Non-covered Recipient Entity
OKLAHOMA HEART RESEARCH AND EDUCATION FOUNDATION
A PHASE 4, PROSPECTIVE, MULTICENTER, SINGLE-ARM STUDY OF A MEAN PULMONARY ARTERY PRESSURE-TARGETED APPROACH WITH EARLY AND RAPID TREPROSTINIL THERAPY TO REVERSE RIGHT VENTRICULAR REMODELING IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION: ARTISAN (AFTERLOAD REDUCTION TO IMPROVE RIGHT VENTRICULAR STRUCTURE AND FUNCTION) No dispute reported 06/30/2026 1242387135
Principal investigator 1 United Therapeutics Corporation $2,210.00 06/11/2025 Non-covered Recipient Entity
OKLAHOMA HEART RESEARCH AND EDUCATION FOUNDATION
A PHASE 4, PROSPECTIVE, MULTICENTER, SINGLE-ARM STUDY OF A MEAN PULMONARY ARTERY PRESSURE-TARGETED APPROACH WITH EARLY AND RAPID TREPROSTINIL THERAPY TO REVERSE RIGHT VENTRICULAR REMODELING IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION: ARTISAN (AFTERLOAD REDUCTION TO IMPROVE RIGHT VENTRICULAR STRUCTURE AND FUNCTION) No dispute reported 06/30/2026 1242387145
Principal investigator 1 United Therapeutics Corporation $3,897.11 05/21/2025 Non-covered Recipient Entity
OKLAHOMA HEART RESEARCH AND EDUCATION FOUNDATION
A PHASE 4, PROSPECTIVE, MULTICENTER, SINGLE-ARM STUDY OF A MEAN PULMONARY ARTERY PRESSURE-TARGETED APPROACH WITH EARLY AND RAPID TREPROSTINIL THERAPY TO REVERSE RIGHT VENTRICULAR REMODELING IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION: ARTISAN (AFTERLOAD REDUCTION TO IMPROVE RIGHT VENTRICULAR STRUCTURE AND FUNCTION) No dispute reported 06/30/2026 1242387153
Principal investigator 1 United Therapeutics Corporation $2,500.00 05/07/2025 Non-covered Recipient Entity
OKLAHOMA HEART RESEARCH AND EDUCATION FOUNDATION
A PHASE 4, PROSPECTIVE, MULTICENTER, SINGLE-ARM STUDY OF A MEAN PULMONARY ARTERY PRESSURE-TARGETED APPROACH WITH EARLY AND RAPID TREPROSTINIL THERAPY TO REVERSE RIGHT VENTRICULAR REMODELING IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION: ARTISAN (AFTERLOAD REDUCTION TO IMPROVE RIGHT VENTRICULAR STRUCTURE AND FUNCTION) No dispute reported 06/30/2026 1242387147
Principal investigator 2 Edwards Lifesciences Corporation $233,370.10 04/28/2025 Non-covered Recipient Entity
Oklahoma Heart Research & Education Foundation
ALT-FLOW II 2022-06 No dispute reported 06/30/2026 1222705938
Principal investigator 1 United Therapeutics Corporation $1,170.00 04/23/2025 Non-covered Recipient Entity
OKLAHOMA HEART RESEARCH AND EDUCATION FOUNDATION
A PHASE 4, PROSPECTIVE, MULTICENTER, SINGLE-ARM STUDY OF A MEAN PULMONARY ARTERY PRESSURE-TARGETED APPROACH WITH EARLY AND RAPID TREPROSTINIL THERAPY TO REVERSE RIGHT VENTRICULAR REMODELING IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION: ARTISAN (AFTERLOAD REDUCTION TO IMPROVE RIGHT VENTRICULAR STRUCTURE AND FUNCTION) No dispute reported 06/30/2026 1242387133
Principal investigator 1 United Therapeutics Corporation $520.00 03/26/2025 Non-covered Recipient Entity
OKLAHOMA HEART RESEARCH AND EDUCATION FOUNDATION
A PHASE 4, PROSPECTIVE, MULTICENTER, SINGLE-ARM STUDY OF A MEAN PULMONARY ARTERY PRESSURE-TARGETED APPROACH WITH EARLY AND RAPID TREPROSTINIL THERAPY TO REVERSE RIGHT VENTRICULAR REMODELING IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION: ARTISAN (AFTERLOAD REDUCTION TO IMPROVE RIGHT VENTRICULAR STRUCTURE AND FUNCTION) No dispute reported 06/30/2026 1242387129
Principal investigator 1 United Therapeutics Corporation $3,897.11 03/17/2025 Non-covered Recipient Entity
OKLAHOMA HEART RESEARCH AND EDUCATION FOUNDATION
A PHASE 4, PROSPECTIVE, MULTICENTER, SINGLE-ARM STUDY OF A MEAN PULMONARY ARTERY PRESSURE-TARGETED APPROACH WITH EARLY AND RAPID TREPROSTINIL THERAPY TO REVERSE RIGHT VENTRICULAR REMODELING IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION: ARTISAN (AFTERLOAD REDUCTION TO IMPROVE RIGHT VENTRICULAR STRUCTURE AND FUNCTION) No dispute reported 06/30/2026 1242387151
Principal investigator 1 United Therapeutics Corporation $1,755.00 02/26/2025 Non-covered Recipient Entity
OKLAHOMA HEART RESEARCH AND EDUCATION FOUNDATION
A PHASE 4, PROSPECTIVE, MULTICENTER, SINGLE-ARM STUDY OF A MEAN PULMONARY ARTERY PRESSURE-TARGETED APPROACH WITH EARLY AND RAPID TREPROSTINIL THERAPY TO REVERSE RIGHT VENTRICULAR REMODELING IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION: ARTISAN (AFTERLOAD REDUCTION TO IMPROVE RIGHT VENTRICULAR STRUCTURE AND FUNCTION) No dispute reported 06/30/2026 1242387141
Principal investigator 1 United Therapeutics Corporation $6,745.43 02/26/2025 Non-covered Recipient Entity
OKLAHOMA HEART RESEARCH AND EDUCATION FOUNDATION
A PHASE 4, PROSPECTIVE, MULTICENTER, SINGLE-ARM STUDY OF A MEAN PULMONARY ARTERY PRESSURE-TARGETED APPROACH WITH EARLY AND RAPID TREPROSTINIL THERAPY TO REVERSE RIGHT VENTRICULAR REMODELING IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION: ARTISAN (AFTERLOAD REDUCTION TO IMPROVE RIGHT VENTRICULAR STRUCTURE AND FUNCTION) No dispute reported 06/30/2026 1242387155
Principal investigator 1 United Therapeutics Corporation $1,625.00 01/29/2025 Non-covered Recipient Entity
OKLAHOMA HEART RESEARCH AND EDUCATION FOUNDATION
A PHASE 4, PROSPECTIVE, MULTICENTER, SINGLE-ARM STUDY OF A MEAN PULMONARY ARTERY PRESSURE-TARGETED APPROACH WITH EARLY AND RAPID TREPROSTINIL THERAPY TO REVERSE RIGHT VENTRICULAR REMODELING IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION: ARTISAN (AFTERLOAD REDUCTION TO IMPROVE RIGHT VENTRICULAR STRUCTURE AND FUNCTION) No dispute reported 06/30/2026 1242387139